Evidence map›Paper›PMID 42236546›Full record

ArticleThe EMBO journal2026

Molecular architecture of OXGR1 reveals an evolutionary conserved mechanisms for metabolite surveillance.

Xinyue Zhang, Yujie Lu, Xinheng He, Shimeng Guo, Changyao Li, Yu Wang, Yuan Gao, Juxia Yao, Qingning Yuan, Yinshan Tang and 9 more

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Xinyue Zhang *School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
Yujie Lu *School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
Xinheng He *State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Shimeng Guo *State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Changyao LiResearch Center for Medicinal Structural Biology, National Research Center for Translational Medicine at Shanghai, State Key Laboratory of Medical Genomics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yu WangState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yuan GaoState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Juxia YaoState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0009-0005-3673-9936
Qingning YuanState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yinshan TangState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0009-0006-5766-4205
Jing HuState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Wen HuState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Zijuan LuoState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Kai WuState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yue WangState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Wanchao YinState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Xin XieSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China. xxie@simm.ac.cn.ORCID http://orcid.org/0000-0003-2314-4800
H Eric XuSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China. eric.xu@simm.ac.cn.ORCID http://orcid.org/0000-0002-6829-8144
Heng LiuState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. liuheng@simm.ac.cn.ORCID http://orcid.org/0000-0001-9195-1191

Funding

CAS Strategic Priority Research Program XDB37030103MOST | National Key Research and Development Program of China (NKPs) 2022YFA1302900MOST | National Key Research and Development Program of China (NKPs) 2022YFC2703105MOST | National Natural Science Foundation of China (NSFC) 32130022MOST | National Natural Science Foundation of China (NSFC) 32501066MOST | National Natural Science Foundation of China (NSFC) 82121005MOST | National Natural Science Foundation of China (NSFC) 82304579MOST | National Natural Science Foundation of China (NSFC) 82330113MOST | National Natural Science Foundation of China (NSFC) 82495184National Key R&D Program "Strategic Scientific andTechnological Innovation Cooperation" Key Project 2022YFE0203600Shanghai Municipal Science and Technology Major Project 2019SHZDZX02STCSM | Natural Science Foundation of Shanghai Municipality () 25ZR1402552the Lingang Laboratory No.LG-GG-202204-01
6 · The paper itself

Abstract

The ability of cells to sense and respond to metabolic signals is fundamental to life, yet the molecular mechanisms underlying metabolite surveillance remain incompletely understood. Here, we elucidate the structural basis of metabolite recognition by OXGR1, a G Protein-Coupled Receptor (GPCR) that senses key intermediates in the tricarboxylic acid (TCA) cycle. Using cryo-electron microscopy, we determined cryo-EM structures of OXGR1 bound to α-ketoglutarate (AKG), itaconate (ITA), and structurally related metabolites succinate (SUC) and maleate (MA). These structures reveal a positively charged binding pocket and an extensive hydrogen-bond network that mediate selective recognition of dicarboxylic acids. In addition, we identify a distinct arrangement of hydrophobic residues that modulates ligand potency and selectivity. Mutational analysis and molecular dynamics simulations further demonstrate that noncanonical micro-switch motifs, including FRY and NLxxY, are essential for ligand recognition and receptor activation. Comparative structural and evolutionary analyses indicate that these mechanisms are conserved across species, underscoring the critical role of OXGR1 in maintaining metabolic homeostasis. Together, our findings define a mechanistic framework for metabolite sensing by OXGR1 and provide a framework for therapeutic modulation of metabolic and inflammatory diseases.

Indexed as

Evolution, MolecularReceptors, G-Protein-CoupledAnimalsBinding SitesCryoelectron MicroscopyHumansKetoglutaric AcidsMaleatesMolecular Dynamics SimulationProtein BindingSuccinatesSuccinic Aciditaconic acidKetoglutaric AcidsMaleatesReceptors, G-Protein-CoupledSuccinatesSuccinic Acid

Identifiers

PMID42236546
PMCPMC13372822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.